MedPath

A computerised psychological treatment for problematic cannabis use and depression in an early psychosis treatment service

Not Applicable
Conditions
Cannabis use
Depression
Cardiovascular Risk
Mental Health - Depression
Mental Health - Addiction
Public Health - Health service research
Registration Number
ACTRN12613000456752
Lead Sponsor
niversity of New South Wales
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot yet recruiting
Sex
All
Target Recruitment
30
Inclusion Criteria

Participants will be currently engaged with the Bondi Junction Community Mental Health Service or the Campbelltown Community Mental Health Service for management of psychotic symptoms, be 18-30 years, and have used cannabis in the month prior to baseline.

Exclusion Criteria

People who cannot understand English sufficiently to complete the SHADE computerised program.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Depressive Symptoms (as measured by the Depression, Anxiety Stress Scale - 21 item)[Baseline, 15 weeks post-baseline and 30-weeks post-baseline];Cannabis use (as measured by the Opiate Treatment Index - Cannabis scale)[Baseline, 15-weeks post-baseline and 6-months post-baseline]
Secondary Outcome Measures
NameTimeMethod
Cardiovascular risk behaviours as measured by items that record Fruit and Vegetable intake (Food Frequency Questionnaire), Tobacco Use (Opiate Treatment Index - Tobacco), Physical Activity (International Physical Activity Questionnaire) and Sedentary Activity (Marshal et al., 2006)[Baseline, 15-weeks post-baseline and 6-month post-baseline];Computer Anxiety (Computer Anxiety Rating Scale)[Baseline, 15-weeks post-baseline and 6-months post-baseline]
© Copyright 2025. All Rights Reserved by MedPath